Virtual Journal Club

Please note: This website is for discussion purposes only. The information provided at this website is not intended to provide treatment advice, or to diagnose or treat any medical disorder. The creator of this website is not responsible for events that occur as a result of decisions made based on the information presented here.

Citations powered by PubMed

Entries Tagged as 'Ann Pharmacother'

Evaluating Outcomes Associated with Alternative Dosing Strategies for Piperacillin/Tazobactam: A Qualitative Systematic Review (February).

January 26th, 2012 · Start a Discussion

Evaluating Outcomes Associated with Alternative Dosing Strategies for Piperacillin/Tazoba…

[Read more →]

Tags: Ann Pharmacother

Ketamine in Adult Emergency Medicine: Controversies and Recent Advances (December).

December 8th, 2011 · Start a Discussion

Ketamine in Adult Emergency Medicine: Controversies and Recent Advances (December).

[Read more →]

Tags: Ann Pharmacother

Takotsubo Cardiomyopathy as a Complication of Electroconvulsive Therapy (December).

November 26th, 2011 · Start a Discussion

Takotsubo Cardiomyopathy as a Complication of Electroconvulsive Therapy (December).

[Read more →]

Tags: Ann Pharmacother

Beers Criteria as a Proxy for Inappropriate Prescribing of Other Medications Among Older Adults (November).

October 9th, 2011 · Start a Discussion

Beers Criteria as a Proxy for Inappropriate Prescribing of Other Medications Among Older Adults (November).
Ann Pharmacother. 2011 Oct 4;
Authors: Lund BC, Steinman MA, Chrischilles EA, Kaboli PJ
Abstract
BACKG…

[Read more →]

Tags: Ann Pharmacother

Clinical outcomes of a collaborative, home-based postdischarge warfarin management service.

October 3rd, 2011 · Start a Discussion

Clinical outcomes of a collaborative, home-based postdischarge warfarin management service.
Ann Pharmacother. 2011 Mar;45(3):325-34
Authors: Stafford L, Peterson GM, Bereznicki LR, Jackson SL, van Tienen EC, Angley MT, Bajorek…

[Read more →]

Tags: Ann Pharmacother

Incidence of Hospitalized Rhabdomyolysis with Statin and Fibrate Use in an Insured US Population (October).

September 16th, 2011 · Start a Discussion

Incidence of Hospitalized Rhabdomyolysis with Statin and Fibrate Use in an Insured US Population (October).
Ann Pharmacother. 2011 Sep 13;
Authors: Amend KL, Landon J, Thyagarajan V, Niemcryk S, McAfee A
Abstract

[Read more →]

Tags: Ann Pharmacother

Evaluation of the Accuracy of a Pharmacokinetic Dosing Program in Predicting Serum Vancomycin Concentrations in Critically Ill Patients (October).

September 9th, 2011 · Start a Discussion

Evaluation of the Accuracy of a Pharmacokinetic Dosing Program in Predicting Serum Vancomycin Concentrations in Critically Ill Patients (October).
Ann Pharmacother. 2011 Sep 6;
Authors: Aubron C, Corallo CE, O Nunn M, Dooley M…

[Read more →]

Tags: Ann Pharmacother

Treating Hypertension in the Very Elderly (September).

August 22nd, 2011 · Start a Discussion

Treating Hypertension in the Very Elderly (September).
Ann Pharmacother. 2011 Aug 18;
Authors: Charpentier MM, Bundeff A
Abstract
OBJECTIVE: To review the evidence for strict blood pressure (BP) management in t…

[Read more →]

Tags: Ann Pharmacother

Intensity of Anticoagulation with Warfarin and Risk of Adverse Events in Patients Presenting to the Emergency Department (July/August).

July 14th, 2011 · Start a Discussion

Intensity of Anticoagulation with Warfarin and Risk of Adverse Events in Patients Presenting to the Emergency Department (July/August).
Ann Pharmacother. 2011 Jul 12;
Authors: Anthony CJ, Karim S, Ackroyd-Stolarz S, Fry A, Mur…

[Read more →]

Tags: Ann Pharmacother

Activated Partial Thromboplastin Time Versus Antifactor Xa Heparin Assay in Monitoring Unfractionated Heparin by Continuous Intravenous Infusion (July/August).

June 30th, 2011 · Start a Discussion

Activated Partial Thromboplastin Time Versus Antifactor Xa Heparin Assay in Monitoring Unfractionated Heparin by Continuous Intravenous Infusion (July/August).
Ann Pharmacother. 2011 Jun 28;
Authors: Guervil DJ, Rosenberg AF, …

[Read more →]

Tags: Ann Pharmacother

Evaluation of a Simplified N-Acetylcysteine Dosing Regimen for the Treatment of Acetaminophen Toxicity (June).

May 20th, 2011 · Start a Discussion

Evaluation of a Simplified N-Acetylcysteine Dosing Regimen for the Treatment of Acetaminophen Toxicity (June).
Ann Pharmacother. 2011 May 17;
Authors: Johnson MT, McCammon CA, Mullins ME, Halcomb SE
BACKGROUND: Acetami…

[Read more →]

Tags: Ann Pharmacother

Pancreatic Enzyme Products: Digesting the Changes (May).

May 5th, 2011 · Start a Discussion

Pancreatic Enzyme Products: Digesting the Changes (May).
Ann Pharmacother. 2011 May 3;
Authors: Giuliano CA, Dehoorne-Smith ML, Kale-Pradhan PB
OBJECTIVE: To review the pharmacology, dosage regimens, efficacy, and safe…

[Read more →]

Tags: Ann Pharmacother

Dabigatran Etexilate: A Novel Oral Thrombin Inhibitor for Thromboembolic Disease (May).

May 5th, 2011 · Start a Discussion

Dabigatran Etexilate: A Novel Oral Thrombin Inhibitor for Thromboembolic Disease (May).
Ann Pharmacother. 2011 May 3;
Authors: Bovio JA, Smith SM, Gums JG
OBJECTIVE: To evaluate the efficacy and safety of dabigatran et…

[Read more →]

Tags: Ann Pharmacother

Efficacy of Agents to Prevent and Treat Enteral Feeding Tube Clogs (May).

April 30th, 2011 · Start a Discussion

Efficacy of Agents to Prevent and Treat Enteral Feeding Tube Clogs (May).
Ann Pharmacother. 2011 Apr 26;
Authors: Dandeles LM, Lodolce AE
OBJECTIVE: To review the efficacy and safety of agents used to prevent and treat…

[Read more →]

Tags: Ann Pharmacother

Vancomycin-Induced Neutropenia: Is it Dose- or Duration-Related? (May).

April 30th, 2011 · Start a Discussion

Vancomycin-Induced Neutropenia: Is it Dose- or Duration-Related? (May).
Ann Pharmacother. 2011 Apr 26;
Authors: Black E, Lau TT, Ensom MH
OBJECTIVE: To systematically evaluate the literature to determine whether vancom…

[Read more →]

Tags: Ann Pharmacother